We are live on
!
Find out more
CAM
Claret Asset Management Portfolio holdings
AUM
$928M
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-2.45%
1 Year Est. Return
+25.4%
3 Year Est. Return
+73.27%
5 Year Est. Return
+90.16%
10 Year Est. Return
–
AUM
$520M
AUM Growth
-$20.8M
(-3.8%)
Cap. Flow
-$457K
Cap. Flow
% of AUM
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
44.27%
Holding
179
New
7
Increased
50
Reduced
56
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$5.91M |
| 2 |
PayPal
PYPL
|
+$4.47M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.35M |
| 4 |
CGI
GIB
|
+$1.15M |
| 5 |
Oaktree Specialty Lending
OCSL
|
+$812K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$4.45M |
| 2 |
AbbVie
ABBV
|
+$1.81M |
| 3 |
Medtronic
MDT
|
+$1.11M |
| 4 |
Hertz
HTZ
|
+$778K |
| 5 |
Aecom
ACM
|
+$710K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.28% |
| 2 | Healthcare | 18.02% |
| 3 | Communication Services | 13.02% |
| 4 | Financials | 11.79% |
| 5 | Consumer Discretionary | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Orion
OEC
$408M
| $412K | 0.08% |
25,768
-709
| -3% | -$12.2K |
|
|
NVO
102
Novo Nordisk
NVO
$207B
| $403K | 0.08% |
7,250
| – | – |
|
103
Oracle
ORCL
$419B
| $403K | 0.08% |
4,876
-15
| -0.3% | -$1.22K |
|
104
iShares MSCI Brazil ETF
EWZ
$8.96B
| $395K | 0.08% |
10,449
-15
| -0.1% | -$485 |
|
105
Vanguard FTSE Developed Markets ETF
VEA
$236B
| $391K | 0.08% |
+8,147
| New | +$396K |
|
106
Mastercard
MA
$496B
| $387K | 0.07% |
1,083
-60
| -5% | -$21.6K |
|
107
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
| $359K | 0.07% |
+2,968
| New | +$370K |
|
108
Franco-Nevada
FNV
$46.5B
| $345K | 0.07% |
2,165
+75
| +4% | +$10.8K |
|
|
GOOS
109
Canada Goose Holdings
GOOS
$861M
| $340K | 0.07% |
12,944
+240
| +2% | +$6.89K |
|
110
Pfizer
PFE
$150B
| $339K | 0.07% |
6,542
+329
| +5% | +$17.1K |
|
111
Fortis
FTS
$28.5B
| $335K | 0.06% |
6,770
+470
| +7% | +$22K |
|
112
XPEL
XPEL
$1.35B
| $329K | 0.06% |
6,255
| – | – |
|
113
OR Royalties Inc
OR
$6.21B
| $315K | 0.06% |
23,895
| – | – |
|
|
TARO
114
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $315K | 0.06% |
7,279
-417
| -5% | -$19.5K |
|
115
S&P Global
SPGI
$121B
| $314K | 0.06% |
+766
| New | +$312K |
|
116
Cable One
CABO
$214M
| $313K | 0.06% |
214
-3
| -1% | -$4.57K |
|
117
Generac Holdings
GNRC
$12.6B
| $313K | 0.06% |
1,053
| – | – |
|
118
Nutrien
NTR
$31B
| $296K | 0.06% |
2,850
-9
| -0.3% | -$746 |
|
119
iShares Global Clean Energy ETF
ICLN
$2.37B
| $291K | 0.06% |
+13,500
| New | +$264K |
|
120
Vanguard Total World Stock ETF
VT
$79.7B
| $289K | 0.06% |
2,855
-151
| -5% | -$15.3K |
|
121
CF Industries
CF
$17.4B
| $287K | 0.06% |
+2,789
| New | +$225K |
|
122
McDonald's
MCD
$195B
| $283K | 0.05% |
1,146
-42
| -4% | -$10.5K |
|
123
HP
HPQ
$26.5B
| $274K | 0.05% |
7,556
-150
| -2% | -$5.54K |
|
124
Turkcell
TKC
$4.78B
| $270K | 0.05% |
69,450
-3,325
| -5% | -$11.9K |
|
|
P
125
Everpure Inc
P
$29.2B
| $267K | 0.05% |
7,571
| – | – |
|
Similar funds
WC
BCC
GP
ICM
TC
CFA
FPI
MHIC
Claret Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Claret Asset Management held 179 positions worth $520M, down 3.8% from $541M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Claret Asset Management's Q1 2022 filing shows 7 new, 50 increased, 56 reduced and 25 closed positions. Its largest new stake was Vanguard FTSE Developed Markets ETF: 8,147 shares worth $391K. The largest sale was Royal Dutch Shell PLC ADS Class B, an estimated $4.45M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Communication Services.
- Claret Asset Management's largest Q1 2022 buy was Vanguard FTSE Developed Markets ETF: 8,147 shares worth $391K.
- Claret Asset Management added most to Meta Platforms (Facebook) in Q1 2022, an estimated $5.91M increase.
- Claret Asset Management's biggest Q1 2022 reduction was AbbVie, cutting an estimated $1.81M.
- Claret Asset Management fully exited Royal Dutch Shell PLC ADS Class B in Q1 2022, selling an estimated $4.45M.
- Claret Asset Management's ten largest holdings make up 44% of its $520M portfolio in Q1 2022.
- Claret Asset Management opened 7 new positions and closed 25 in Q1 2022.
- Claret Asset Management's portfolio value fell 3.8% quarter-over-quarter to $520M.
Based on Claret Asset Management's 13F filing for Q1 2022, filed 4 Apr 2022.